![JAMA on X: "Low-Dose Aspirin For Primary Prevention of Cardiovascular Disease - Share The Decision! https://t.co/r4gxUeFxRL https://t.co/BudUieIBjS" / X JAMA on X: "Low-Dose Aspirin For Primary Prevention of Cardiovascular Disease - Share The Decision! https://t.co/r4gxUeFxRL https://t.co/BudUieIBjS" / X](https://pbs.twimg.com/media/DIhdzmyXgAA1lAp.jpg)
JAMA on X: "Low-Dose Aspirin For Primary Prevention of Cardiovascular Disease - Share The Decision! https://t.co/r4gxUeFxRL https://t.co/BudUieIBjS" / X
![2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines | Circulation 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines | Circulation](https://www.ahajournals.org/cms/asset/a0a9b95e-a13e-40f7-8709-8fd7a320d3d4/e596tab11.gif)
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines | Circulation
![Aspirin for Primary Prevention of Cardiovascular Events in Relation to Lipoprotein(a) Genotypes | Journal of the American College of Cardiology Aspirin for Primary Prevention of Cardiovascular Events in Relation to Lipoprotein(a) Genotypes | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/3b6bc904-82dd-453f-b44c-9bafa2480a05/fx1.jpg)
Aspirin for Primary Prevention of Cardiovascular Events in Relation to Lipoprotein(a) Genotypes | Journal of the American College of Cardiology
![Muin J. Khoury on X: "Low Dose Aspirin in the Primary Prevention of Cardiovascular Disease: #USPSTF recommends individualized decision making between 50 and 59 years, and against aspirin use in 60 years+. Muin J. Khoury on X: "Low Dose Aspirin in the Primary Prevention of Cardiovascular Disease: #USPSTF recommends individualized decision making between 50 and 59 years, and against aspirin use in 60 years+.](https://pbs.twimg.com/media/FBg19vmXsAUnJ3w.png:large)